Hepato-lenticular degeneration, also known as Wilson disease, is a rare inherited disorder where the body cannot properly remove excess copper, causing it to build up in vital organs and potentially leading to life-threatening complications if left untreated.

Wilson disease represents one of the few treatable genetic conditions affecting copper metabolism in the human body. While copper plays an essential role in building healthy nerves, bones, collagen, and the skin pigment melanin, the body only needs tiny amounts of this mineral. In people with this condition, a faulty gene disrupts the normal process of copper removal, causing toxic accumulation primarily in the liver, brain, and eyes. Although present from birth, symptoms typically don’t appear until copper levels reach dangerous concentrations in affected organs^[1][2].

The condition takes its name from British neurologist Samuel Wilson, who described it in detail, though it was first observed by German pathologist Friedrich Theodor von Frerichs in 1854. Understanding this disease is crucial because early detection and lifelong management can mean the difference between living a normal, healthy life and facing severe, potentially fatal complications. Without treatment, the disease invariably leads to death, particularly from acute liver failure^[4].

Epidemiology

Wilson disease affects approximately one in 30,000 people worldwide, making it a relatively rare condition. However, the actual prevalence may be higher in certain isolated populations where genetic factors concentrate due to limited gene pools^[1][4][6].

The estimated prevalence at birth ranges between 1 in 30,000 to 1 in 110,000 across different global populations. This variation reflects differences in genetic backgrounds, diagnostic capabilities, and awareness levels in different regions. Some communities with less genetic diversity may see higher rates of the condition due to increased likelihood of both parents carrying the faulty gene^[6].

Most people with Wilson disease are diagnosed between the ages of 5 and 35 years, though both younger children and older adults can be affected. The age at which symptoms appear varies considerably, even among members of the same family who share the same genetic mutations. Some patients remain without obvious symptoms for decades, while a few develop signs before age 3 to 5. The majority of cases become apparent by age 40, though late-onset presentations after the fifth decade of life have been documented^[2][6].

Demographic patterns show that clinical presentation often depends on both age and gender. Children typically present with liver-related symptoms at an average age of around 10 years. Adults more commonly develop neurological and psychiatric manifestations, usually appearing in their twenties or later. Hepatic manifestations generally precede neurological symptoms, though neurological problems can sometimes be the first noticeable signs of the disease^[6][7].

Causes

Wilson disease is an autosomal recessive genetic disorder, which means it follows a specific pattern of inheritance. For a person to develop the condition, they must inherit two copies of the faulty gene—one from each parent. People who inherit only one faulty gene are called carriers. Carriers don’t develop symptoms themselves, but they can pass the defective gene to their children^[1][4].

The underlying cause is mutations in a gene called ATP7B, located on chromosome 13. This gene provides instructions for making a protein that acts as a copper-transporting enzyme. In healthy individuals, this protein works inside liver cells to move excess copper into bile, a digestive fluid produced by the liver. The copper-containing bile then travels through the digestive system and leaves the body through waste products^[1][4].

When the ATP7B gene is mutated, the resulting protein doesn’t function properly. Without a working copper transport mechanism, the liver cannot package excess copper into bile for excretion. Instead, copper begins to accumulate inside liver cells. Over time, as the liver’s storage capacity is overwhelmed, copper spills directly into the bloodstream and travels to other organs, where it deposits and causes damage^[11][13].

Another consequence of the defective ATP7B protein is the failure to properly incorporate copper into ceruloplasmin, a protein in the blood that normally carries copper. The liver still produces ceruloplasmin, but without copper attached to it—a form called apoceruloplasmin. This copper-free version breaks down much faster than normal ceruloplasmin, resulting in the characteristically low blood levels of ceruloplasmin seen in most Wilson disease patients^[8].

Risk Factors

The primary risk factor for developing Wilson disease is having a family history of the condition. If a parent or sibling has been diagnosed with Wilson disease, other family members face an increased risk and should consider genetic testing. This testing can determine whether someone is a carrier of the faulty gene or has inherited two copies and is at risk of developing symptoms^[2][10].

Because Wilson disease is an inherited genetic condition, there are no behavioral or environmental risk factors that cause it. Unlike many liver diseases, it is not related to alcohol consumption, viral infections, or lifestyle choices. The disease is entirely determined by genetic inheritance patterns^[19].

Individuals with both parents who are carriers of the ATP7B gene mutation have a one in four chance of developing Wilson disease. Family members of diagnosed patients should undergo genetic counseling and testing, even if they feel healthy, because the disease can progress silently for years before symptoms appear. Early identification of affected family members allows treatment to begin before organ damage occurs^[10].

Certain populations with limited genetic diversity may have higher carrier rates, increasing the statistical likelihood of Wilson disease. In such communities, more people may unknowingly carry the faulty gene, making it more probable that two carriers will have children together^[6].

Symptoms

Wilson disease is present at birth, but symptoms don’t appear until copper builds up to toxic levels in organs. The symptoms a person experiences depend on which parts of the body have been most affected by copper accumulation. The clinical picture can be very wide-ranging, and symptoms often vary dramatically even among members of the same family^[2][6].

Liver-Related Symptoms

Because copper initially accumulates in the liver, liver-related symptoms are often the first to appear, especially in children and teenagers. These symptoms can include persistent tiredness and fatigue, loss of appetite, weight loss, nausea, and vomiting. Some people develop jaundice, which is a yellowing of the skin and the whites of the eyes caused by liver dysfunction^[2][4].

As copper damage progresses, the liver may become enlarged, causing abdominal pain or bloating. Fluid can build up in the abdomen, a condition called ascites, and in the legs, causing swelling or edema. Itching of the skin may occur, along with an increased tendency to bruise or bleed easily. Some people develop spider angiomas, which are visible branch-like blood vessels on the skin. Muscle cramps can also occur as liver function declines^[4][15].

In some cases, the liver damage can progress to cirrhosis, where healthy liver tissue is replaced by scar tissue. Cirrhosis can lead to portal hypertension, a dangerous condition where pressure builds up in the blood vessels that supply the liver. This can cause serious complications including confusion due to hepatic encephalopathy, a condition where toxins that the damaged liver cannot remove affect brain function^[4][7].

Neurological and Psychiatric Symptoms

When copper accumulates in the brain, particularly in structures called the basal ganglia, neurological symptoms develop. These symptoms tend to appear later than liver symptoms, often in people in their twenties or older. Common neurological signs include tremors, muscle stiffness, and difficulty controlling movements. People may experience problems with coordination, making walking difficult or causing clumsiness with hand movements^[1][3].

Speech problems are common, including difficulty articulating words (dysarthria) or speaking in a very quiet voice (hypophonia). Some people develop abnormal involuntary movements called dyskinesias, including jerky, slow movements that are hard to control. Dystonia, which causes sustained muscle contractions, and chorea or choreoathetosis, which involve dance-like writhing movements, may also occur^[6][7].

Memory problems, vision impairment, migraines, drooling, and insomnia can affect daily functioning. Swallowing difficulties may develop, making eating challenging. In advanced stages, muscle spasms, seizures, and muscle pain during movement can occur^[2][15].

Psychiatric symptoms are also common and may include depression, anxiety, mood swings, personality changes, or aggressive behavior. Some people experience emotional instability, phobias, or compulsive behaviors. In rare cases, individuals may develop psychotic symptoms such as auditory or visual hallucinations. Isolated psychiatric symptoms without accompanying liver or neurological signs are uncommon but possible^[1][6][7].

Eye-Related Symptoms

A characteristic sign of Wilson disease is the appearance of Kayser-Fleischer rings. These are golden-brown or rusty-brown rings that form around the outer edge of the cornea, the clear front surface of the eye. They result from copper deposits in a part of the eye called Descemet’s membrane. While these rings don’t usually cause vision problems, they are an important diagnostic marker. Not everyone with Wilson disease has visible Kayser-Fleischer rings, but they are more common in people with neurological symptoms^[2][6][10].

Another eye finding is the sunflower cataract, a specific type of lens clouding that resembles the petals of a sunflower. This finding is also indicative of copper accumulation but doesn’t typically affect vision^[10].

Other Organ Systems

Beyond the liver, brain, and eyes, copper accumulation can affect other parts of the body. The kidneys may be damaged, leading to problems such as blood in the urine (hematuria), protein in the urine (nephrotic syndrome, or kidney stones (renal lithiasis). The condition can cause proximal renal tubular dysfunction, affecting how the kidneys handle various substances^[1][6].

The heart can be affected, leading to abnormal heart rhythms (arrhythmia) or nonischemic cardiomyopathy, a condition where the heart muscle weakens. Bones and joints may also be involved, causing bone pain, joint pain (arthralgia), or osteoporosis, a condition where bones become weak and brittle^[1][6].

Some people with Wilson disease experience acute episodes of hemolytic anemia, where red blood cells are destroyed faster than the body can replace them. Women may experience reproductive issues such as delayed puberty, absence of menstrual periods (amenorrhea), or repeated miscarriages^[6][16].

Prevention

Because Wilson disease is an inherited genetic condition, there is no way to prevent the disease itself from being passed from parents to children. However, early detection and timely treatment can prevent the development of symptoms and complications, allowing people with the condition to live normal, healthy lives^[2][5].

Genetic testing plays a crucial role in prevention of disease progression. Family members of someone diagnosed with Wilson disease should undergo genetic testing to determine if they have inherited the condition. Testing can identify affected individuals before symptoms appear, enabling treatment to begin early and prevent organ damage. Screening is especially important for siblings and children of affected individuals^[1][6].

For individuals already diagnosed with Wilson disease, following a low-copper diet is an important preventive measure, particularly in the early stages of treatment. This involves avoiding foods that are naturally high in copper, such as liver, shellfish (including oysters, scallops, shrimp, lobster, clams, and crab), mushrooms, nuts, seeds, chocolate, dried beans, dried peas, lentils, and certain whole grains like wheat germ and bran. Commercially dried fruits such as raisins, dates, and prunes should also be limited^[5][18].

People with Wilson disease should avoid taking multivitamins or supplements that contain copper. Always check supplement labels carefully, and consult with a pharmacist if help is needed finding a copper-free multivitamin. Most prenatal vitamins are high in copper and should be avoided; pregnant women with Wilson disease should work closely with both their liver specialist and obstetrician to find appropriate supplementation^[5][18].

Alcohol consumption should be avoided or strictly limited, as it can further damage the liver, which may already be weakened by copper accumulation and cirrhosis^[18][19].

Pathophysiology

The pathophysiology of Wilson disease centers on the body’s inability to maintain proper copper balance. In healthy individuals, dietary copper is absorbed from food in the small intestine. The body needs only about 1 to 2 milligrams of copper daily for normal enzyme function. Copper serves as an essential component of several important enzymes, including tyrosinase, cytochrome oxidase, and superoxide dismutase. These enzymes play vital roles in various biological processes^[3].

After absorption, copper travels to the liver, where a complex regulatory system manages its distribution and excretion. In healthy liver cells, the ATP7B protein transports excess copper into bile, which then flows into the intestines and leaves the body through feces. This enterohepatic circulation maintains copper balance. Most copper in the bloodstream is bound to ceruloplasmin, and only about 5% exists as free copper ions bound to other proteins^[3][8].

In Wilson disease, mutations in the ATP7B gene produce a defective or absent copper-transporting protein. This causes two major problems. First, the liver cannot excrete excess copper into bile effectively, so copper accumulates inside liver cells. Second, the liver cannot properly incorporate copper into ceruloplasmin during its production, resulting in low blood levels of functional ceruloplasmin^[8].

As copper builds up in liver cells, it causes inflammation and damage, a condition called hepatitis. The inflammation can be acute or chronic. Over time, continued copper accumulation leads to scarring (fibrosis) and eventually cirrhosis, where healthy liver tissue is replaced by scar tissue that cannot perform normal liver functions^[6][19].

When the liver’s capacity to store copper is exceeded, free copper ions are released directly into the bloodstream. These copper ions then travel throughout the body and deposit in other organs. Copper is particularly toxic to the brain, where it accumulates in the basal ganglia—specifically the putamen and pallidum—which are structures that control movement. Copper deposits also form in the kidneys, eyes, heart, and bones^[1][3].

Free copper ions are highly toxic because they can trigger harmful chemical reactions. Similar to iron, copper participates in reactions that generate damaging molecules called hydroxyl radicals through the Fenton reaction. These radicals cause oxidative stress, which damages cell membranes through lipid peroxidation, disrupts mitochondrial function (the energy-producing structures in cells), interferes with calcium balance inside cells, and ultimately leads to cell death^[3].

The brain damage caused by copper is thought to be largely irreversible. Even when excess copper is removed through treatment, neurological symptoms may persist, suggesting permanent destruction of brain tissue. This is supported by observations that neurological problems often remain after liver transplantation, a procedure that corrects the copper metabolism defect but cannot repair damage already done to the nervous system^[3].

In the eyes, copper deposits in the Descemet membrane of the cornea create the characteristic Kayser-Fleischer rings. These rings appear as golden-brown or rusty circles around the outer edge of the colored part of the eye. The exact mechanism by which copper crosses the blood-brain barrier—a protective barrier that normally prevents harmful substances from entering the brain—is not fully understood. However, once copper enters the brain, it damages specific neuronal functions and metabolic processes^[3][6].

The kidneys are affected through copper deposition that disrupts the normal functioning of the proximal renal tubules, the part of the kidney that reabsorbs important substances from urine. This can lead to loss of amino acids, glucose, phosphate, and other nutrients in the urine^[1].

In some cases, copper accumulation causes acute destruction of red blood cells, resulting in hemolytic anemia. This contributes to jaundice, as the breakdown products of red blood cells overwhelm the already-damaged liver’s ability to process them^[1][7].

The severity and progression of organ damage vary widely among individuals, even those with identical genetic mutations. This variability suggests that other genetic or environmental factors may influence how the disease manifests. Understanding the complex pathophysiology of Wilson disease has been crucial in developing effective treatments aimed at reducing copper levels and preventing further organ damage^[6].